United States · FDA National Drug Code directory
MEPROBAMATE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 46708-019_8c5c7ad8-a128-4243-bd03-0e7057295b3f
- Product NDC
- 46708-019
- Form
- TABLET
- Composition / generic term
- MEPROBAMATE
- Labeler
- Alembic Pharmaceuticals Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20130723
- Source listing expiry
- 20261231
Source-listed ingredients
- MEPROBAMATE — 200 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET in 1 BOTTLE (46708-019-30) · 46708-019-30
- 100 TABLET in 1 BOTTLE (46708-019-71) · 46708-019-71
- 1000 TABLET in 1 BOTTLE (46708-019-91) · 46708-019-91
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →